A Fred Hutch Cancer Center team led by TRACER founder and director Dr. Taran Gujral has found a potential therapeutic target for fibrolamellar carcinoma, a rare liver cancer that mostly affects teens and young adults — and they’ve identified likely drug candidates that may provide the first novel treatment for this deadly disease. The discovery aligns with Fred Hutch’s broader efforts to spotlight rare cancers, including its semiannual Rare Cancer Research Symposium.
Read the full story here:
https://www.fredhutch.org/en/news/center-news/2025/05/rare-cancer-researchers-promising-target-kinase-fibrolamellar-cancer.html
